Archive for October 2018

Nevada Woman Charged With Selling Fake Fentanyl Pill That Killed A 26-Year-Old

A Henderson, Nevada woman has been charged in federal court for allegedly selling the counterfeit oxycodone pills made with fentanyl that killed 26-year-old Christiana Kuerner on March 14, 2017. Assistant Special Agent in Charge Daniel Neill of the DEA said fentanyl seizures are increasing in the southern part of the state, with 20,000-30,000 pills being found at a time…

[...]

Drug Importation and the Deadly Challenge of Screening 275 Million Packages a Year

The Food and Drug Administration (FDA) in their report U.S. Food and Drug Administration and the International Mail Facilities (IMFs), describes the daunting job that Customs and Border Protection (CBP) faces when attempting to weed out counterfeit medications and packages containing illicit fentanyl. In 2017, IMFs received 275 million packages. Of these, 10,000 were screened by CBP, and of those 86% contained drugs. The investigation of a suspect package is incredibly time-consuming; an experienced FDA investigator might take as long as 20 minutes to process a package containing just on product.

[...]

Mississippi

Our 2018 information sheet summarizes recent counterfeit drug incidents in Mississippi.

[...]

US FDA Joins Interpol and Other International Enforcement Agencies for Operation Pangea XI

The United States Food and Drug Administration (FDA) has announced the conclusion of Operation Pangea XI’s International Week of Action. In its eleventh year, Operation Pangea targets websites that sell counterfeit and misbranded drugs. This year’s effort shut down 465 websites that were selling non-FDA approved prescription drugs including drugs for oncology, antivirals, opioids and other untested prescription drugs to U.S. consumers.

[...]

The STOP Act Will Be A Critical Tool In The Detection Of Illegal Substances In International Mail Shipments

The board members of The Partnership for Safe Medicines praise the passage of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act” or the “SUPPORT for Patients and Communities Act, which includes the STOP Act. This legislation will have a positive impact on the fight to save lives and keep fentanyl out of the United States…

[...]